Patent Assignment
Reel/Frame 058079/0045
Assignment of Assignor's Interest
Recorded: 2021-11-10
Pages: 4
Assignee
EDISON PHARMACEUTICALS, INC.
350 NORTH BERNARDO AVENUE, MOUNTAIN VIEW, CALIFORNIA, 94043
Covered Property
(1)
Redox-Active Therapeutics for Treatment of Mitochondrial Diseases and Other Conditions and Modulation of Energy Biomarkers
Application:
17/334,601 →
Publication:
US 2022/0055975
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Nov 11, 2021
From: EDISON PHARMACEUTICALS, INC.
To: BIOELECTRON TECHNOLOGY CORPORATION
Reel/Frame 058318/0063 →
Assignment of Assignor's Interest
Nov 12, 2021
From: BIOELECTRON TECHNOLOGY CORPORATION
To: PTC THERAPEUTICS, INC.
Reel/Frame 058318/0066 →
Security Interest
Oct 28, 2022
From: PTC THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 061803/0878 →
Termination and Release of Patent Security Agreement @ Reel 061803 and Frame 0878
Oct 20, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 065303/0163 →